Documente Academic
Documente Profesional
Documente Cultură
Tipul 2
- Necroza miocardica <- dezechilibru intre
oferta/cerere O2 dar nu din cauza instabilitatii
placii.
- Cauze:
1. Spasmul coronarian
2. Disfunctia endoteliala
3. Tahiaritmiile
4. Bradiaritmiile
5. Anemia
6. Insufic. Resp.
7. hTA
8. HTA severa
Tipul 3:
Decesul survenit in urma unui IM (nu
sunt disponibil biomarkeri)
Tipul 4:
Cauzat de PTCA
Tipul 5:
Cauzat de CABG (by-pass)
CE ESTE ANGINA
INSTABILA?
Ischemie miocardica de repaus/effort
minim, in absenta necrozei
Comparativ cu NSTEMi -> cei cu AI
nu au necroza, au un risc< M si nu au
un beneficiu > in urma DAAP/trat.
Invaziv precoce.
Ex. obiectiv
Nu este remarcabil la pacientii cu SCA-NSTE.
Pot fi + semne de IC/instabilitate electrica
sau clinica -> diagnostic+trat.> rapide
Auscultatia:
suflu sistolic de RM ischemica => prognostic
<prost
Suflu sistolic SAo (mimeaza SCA)
Suflu sistolic -> Complicatie mecanica a unei
IM subacut/nedetectat (ruptura muschi
papilar/DSV)
DIAGNOSTIC
Biomarkeri, >hsTI
ECG 12 derivatii -> ideal in primele
10minute de la sosirea intr-o unitate
medicala
SCA-NSTE => ECG normal in 1/3 cazuri =>
daca pacientul prezinta simptomatologie
persistenta si derivatiile standard
concludente => derivatii suplimentare:
- V7-V9 -> Acx
- V3R, V4R -> ACD
<-> STE persistenta + semne/simptome
sugestive ischemie => reperfuzie imediata
Spasm coronarian
Evenim. acute neurologice (AVC/hemoragie
subarahnoidiana)
Contuzie cardiaca/proceduri cardiace (PCI,
CABG, ablatie, pacing, cardioversie, biopsie
endomiocardica)
Boli infiltrative (amiloidoza, hemocromatoza,
sarcoidoza, sclerodermie)
Toxice pe miocard (doxorubicina, 5-FU,
herceptin, venin)
Efort fizic exagerat
rabdomioliza
ECG IN BRS/RITM
ELECTROSTIMULAT?
Diagnosticul=DIFICIL
IMA poate fi mascat
Criteriile Sgarbossa
pot fi utilizate:
PREZENTARE DE CAZ
MOTIVELE INTERNARII:
Dureri
ANTECEDENTE HEREDOCOLATERALE:
tatal
Scleroza
COMPORTAMENTE:
Fumatoare
Cafea
1/zi
Interferon
Prednison
250
ISTORICUL BOLII
Recomandari pt diagnosticul
initial al pacientilor cu
suspiciune de STEMI
Tabel
1
Tabel
2
Stare
IMC
Stare
Facies
necaracteristic
Tegumente,
hidratate
Fanere
Tesut
eutrofice
Sistem
Sistem
Sistem
PARACLINIC:
ECG
de repaus cu 12 derivatii
Figura 1
traseul
ECG
in17.01.20
15 la
SCMUT
Figura 2 ECG la
internare in Clinica
noastra, in 18.01.2015
RS, FC=100b/min, ax
QRS intermediar,
supradenivelare de
segment ST de aprox.
4mm in V2-V5, q in
DIII, QS in V1-V3
Na=137-136-140mmol/l
HCT = 44,7%
K=4,2-4-3,8mmol/l
Hb = 15,1-13,1-14,2-13,4g/dl
Leucocite = 16100-16560-14140-13180/mmc
Trombocite = 145000-242000-280000-282000/mmc
VSH=10mm/h
Glicemia=126-88-101mg/dl
Colesterol total=248mg/dl
LDL-c=129mg/dl
HDL-c=44mg/dl
Trigliceride=420mg/dl
CK total=195-3712-1541-256-170-112U/l
CK-MB=60-582-229-24U/l
Troponina =0,09ng/ml
AST=27-277-190-70-40-46U/l, ALT=26-70-60-40-29-25U/l
LDH=203-1080-1165-1182-713-871U/l
Diagnostic
pozitiv:
Tabel 3
Tabel 4
PCI primar: indicatii
si aspect legate de
procedura
Tabel 5
Contraindicatii
ale fibrinolizei
Ecocardiografia transtoracica
ANGIOCORONAROGRAFIE
ADA
inainte de
stentare
Figur
a3
Figura
4
ADA
dupa
stentar
e
post PTCA
POST
PTCA
ACD
dupa
stenta
re
Diagnostic la externare:
Renuntarea
Control
Reevaluare
Tratament
Nebivolol
medimentos cu:
5mg 1-0-0
Zofenopril
30mg 0-1/2-0
Ticagrelor
90mg 1-0-1
Acid
Atorvastatina
Pantoprazol
80mg 0-0-1
40mg 1-0-0
Particularitatea cazului:
Varsta
Cumulul
Prezenta
Prezenta
Aparitia
afectarii bivasculare
Scleroza multipla (SM) = boala imprevizibila consecinte de la relativ benigne dezastruoase (1).
CONCLUZII
Bibliography
http://www.ncbi.nlm.nih.gov/pubmedhealth/PMHT0024311/
http://www.ncbi.nlm.nih.gov/pubmed/23364857
http://www.nhs.uk/MedicineGuides/Pages/MedicineSideEffects.aspx?condition=Multiple
%20sclerosis%20and%20other%20demyelinating
%20conditions&medicine=Interferon%20beta1b&preparation=
http://www.drugs.com/dosage/interferon-beta-1a.html
http://www.ehealthme.com/quick_search/myocardial-infarct
ion
Kigerl KA, Gensel JC, Ankeny DP, Alexander JK, Donnelly
DJ, Popovich PG: Identification of two distinct macrophage
subsets with divergent effects causing either neurotoxicity
or regeneration in the injured mouse spinal cord.
http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0068969/